Corcept Therapeutics (CORT)
(Real Time Quote from BATS)
$30.54 USD
-0.67 (-2.15%)
Updated May 31, 2024 10:24 AM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 0.23 |
EPS Last Quarter | 0.25 |
Last EPS Surprise | 19.05% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.95 |
Next Year | 1.42 |
EPS (TTM) | 1.06 |
P/E (F1) | 32.72 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 153.93M | 161.19M | 632.54M | 645.71M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 158.30M | 163.80M | 645.53M | 708.00M |
Low Estimate | 152.35M | 158.60M | 620.60M | 556.33M |
Year ago Sales | 117.72M | 123.60M | 482.38M | 632.54M |
Year over Year Growth Est. | 30.76% | 30.41% | 31.13% | 2.08% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.23 | 0.23 | 0.95 | 1.42 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | 0.20 | 0.18 | 0.88 | 1.19 |
High Estimate | 0.28 | 0.29 | 1.11 | 1.81 |
Low Estimate | 0.20 | 0.18 | 0.86 | 1.19 |
Year ago EPS | 0.25 | 0.28 | 0.94 | 0.95 |
Year over Year Growth Est. | -8.00% | -17.86% | 1.06% | 49.26% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 3 | 2 | 2 | 1 |
Up Last 60 Days | 3 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.23 | 0.23 | 0.95 | 1.42 |
7 Days Ago | 0.23 | 0.23 | 0.95 | 1.41 |
30 Days Ago | 0.24 | 0.23 | 0.92 | 1.33 |
60 Days Ago | 0.24 | 0.23 | 0.92 | 1.30 |
90 Days Ago | 0.21 | 0.21 | 0.87 | 1.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.23 | 0.23 | 0.92 | 1.41 |
Zacks Consensus Estimate | 0.23 | 0.23 | 0.95 | 1.42 |
Earnings ESP | 0.00% | 0.00% | -4.09% | -1.02% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.25 | 0.28 | 0.28 | 0.25 | NA |
Estimate | 0.21 | 0.25 | 0.22 | 0.15 | NA |
Difference | 0.04 | 0.03 | 0.06 | 0.10 | 0.06 |
Surprise | 19.05% | 12.00% | 27.27% | 66.67% | 31.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more